-
Health Assessment & Technology Evaluation Market to Reach $3.3B by 2033 at 15.8% CAGR Driven by Gene Therapy Innovation
27 Feb 2026 13:31 GMT
… strategies.
Mergers & Acquisitions:
November … , companies are increasingly investing in … market serves government agencies, healthcare providers, insurance companies, pharmaceutical and biotechnology companies … Growing investments in healthcare …
-
Transcriptomics Technologies Market: RNA-Sequencing Leads as Precision Medicine Drives Global Demand| DataM Intelligence
27 Feb 2026 11:59 GMT
…
➤ Pharmaceutical and biotechnology companies represent the largest … mergers & acquisitions. Key players operating in the market … share of the transcriptomics technologies market, supported by strong investments … France are investing heavily in genomic …
-
Plant-Based Food & Beverages Market to Reach US$ 48.25B by 2031, led by Asia Pacific's 35.84 Market share
27 Feb 2026 08:04 GMT
… like strategic acquisitions and product innovations … , and biofuel sectors, improving vertical integration … market share in food/beverages is essentially zero despite biotech expertise.
Kowa Company … S. food companies are increasingly investing in plant …
-
Celljevity’s Path to Being Public: What Retail Investors Need to Know About Clinical-Stage Biotech Listings
27 Feb 2026 06:07 GMT
… investment decisions. Investing in clinical-stage biotechnology companies … the sector through substantial acquisitions: … market conditions, comparable company performance, and institutional demand.
Valuation Methodologies: How Institutional Investors …
-
How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?
27 Feb 2026 02:26 GMT
… , and industrial markets worldwide. The company is headquartered … supported by significant investment in research … stock has been under pressure mainly because investors … biotech demand. In comparison, its competitor IDEXX Laboratories, Inc. (IDXX) shares …
-
Why MannKind Stock Tumbled on Thursday
27 Feb 2026 01:39 GMT
… week. Investors eagerly sold out of the commercial-stage biotech'; … year 2025 results before market open, reporting that revenue … the company's portfolio following the October 2025 acquisition of … of $0.02 per share for non-GAAP (adjusted) …
-
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
26 Feb 2026 13:00 GMT
… equivalents, and investments totaling $156.1 … Investors” section of the company website at: www.nautilus.bio. About Nautilus Biotechnology … per share attributable to common stockholders, basic … asset acquisition
—
(760
)
Net cash provided by investing …
-
Precision Medicine Market 2026–2031 Growth: 13%+ CAGR as AI Integration and Biomarker Advancements Drive Adoption, Reports Mordor Intelligence
26 Feb 2026 10:52 GMT
… market features a mix of global pharmaceutical companies, biotechnology … investing in advanced analytics platforms. Market participants are prioritizing strategic partnerships, mergers … of industries, … communications technology, investment opportunities, and …
-
Lipid Nanoparticle Manufacturing Market to Reach US$2,176.3 Mn by 2033 | Persistence Market Research
25 Feb 2026 15:15 GMT
… Biotech and Pharma Investment
Rising investments across global biotechnology and pharmaceutical sectors … partnerships, mergers, and acquisitions enable resource … growing investor confidence position … companies in the lipid nanoparticle manufacturing market …
-
Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions
25 Feb 2026 14:05 GMT
… medical tourism sectors, with … acquisition leverage Totaligent's precision marketing capabilities to target AI-biotech … enables innovative biotech companies developing next … Company undertakes no obligation to update any forward-looking statements. Investor …